Molecular Partners AG MOLN
2.49 USD -0.17 (-6.57%)
Regular-session close
2.56 +0.07 +2.81%
After hours · Nov 19, 4:10 PM ET
2.67 Day range 2.77
2.63 52-week range 5.36
- YTD
- -42.89%
- 1 year
- -40.57%
News
globenewswire.com Molecular Partners to Present at Inaugural UBS Global Biopharma Conference ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX, NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of medicines…benzinga.com Molecular Partners Says MP0632 Preclinical Data At SITC 2026 Show No Detectable Impact On Healthy Mesothelial Or Epithelial Cells, Supporting IND-Enabling Studies In MSLN And EpCAM Solid Tumors Logic-gated Switch-DARPin design enables potent, selective cytotoxicity against cells co-expressing tumor-associated antigens (TAAs) previously considered undruggable for T cell engagersFavorable…
benzinga.com Molecular Partners Q3 EPS $(0.38) Beats $(0.46) Estimate Molecular Partners (NASDAQ:MOLN) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.46) by 17.39 percent. This is a 76.97 percent increase over losses of…
